Journal
JOINT BONE SPINE
Volume 86, Issue 3, Pages 381-382Publisher
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.jbspin.2019.01.019
Keywords
Rheumatoid arthritis; Multiple myeloma; Proteasome inhibitor
Categories
Ask authors/readers for more resources
The proteasome inhibitor bortezomib has been proven effective in the treatment of multiple myeloma. We report on 3 patients with rheumatoid arthritis and multiple myeloma in whom bortezomib therapy was associated with improvements in the joint manifestations. The contribution to this effect of the concomitant glucocorticoid therapy is discussed. (C) 2019 Published by Elsevier Masson SAS on behalf of Societe francaise de rhumatologie.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available